A Shares Outstanding History
Below is a table of the A shares outstanding history going back to 1/31/2010:

Date A Shares Outstanding
1/31/2010486.71M
4/30/2010486.59M
7/31/2010484.23M
11/30/2010485.95M
1/31/2011482.48M
4/30/2011486.57M
7/31/2011485.41M
12/1/2011486.68M
1/31/2012485.98M
4/30/2012485.81M
7/31/2012487.12M
12/1/2012486.41M
1/31/2013485.33M
4/30/2013481.58M
7/31/2013462.45M
12/1/2013463.87M
1/31/2014466.12M
4/30/2014465.90M
7/31/2014466.25M
12/1/2014335.32M
1/31/2015335.81M
4/30/2015333.19M
8/31/2015331.40M
12/1/2015332.17M
1/31/2016327.77M
4/30/2016325.52M
8/31/2016324.38M
12/1/2016321.75M
2/28/2017322.30M
5/31/2017321.34M
8/31/2017321.83M
12/1/2017323.02M
2/28/2018322.48M
5/24/2018319.95M
8/24/2018318.77M

Also see: A Market Cap History
and A YTD Return
A Historical Shares Outstanding:
-4.82% CAGR
A Historical Shares Outstanding: +-4.82% CAGR

Mouse over chart for data details
1/31/2010 ...8/24/2018
Agilent Technologies engages in life sciences, diagnostics and applied chemical markets, providing application focused solutions including instruments, software, services and consumables. Co.'s life sciences and applied markets business provides solutions including instruments and software to identify, quantify and analyze the physical and biological properties of substances and products, and interrogate samples at the molecular level. The diagnostics and genomics business includes genomics, nucleic acid contract manufacturing and the pathology, companion diagnostics and reagent partnership businesses. The CrossLab business spans the entire lab with its consumables and services portfolio. We show 35 historical shares outstanding datapoints in our coverage of A's shares outstanding history.

Understanding the changing numbers of A shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like A versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching A by allowing them to research A shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for A:
A SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Agilent Technologies (A) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AAC Shares Outstanding History
ABAX Shares Outstanding History
ABBV Shares Outstanding History
ABC Shares Outstanding History
ABEO Shares Outstanding History
ABIO Shares Outstanding History
ABMD Shares Outstanding History
ABT Shares Outstanding History
ACAD Shares Outstanding History
ACER Shares Outstanding History
More Healthcare companies »

 

A Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2018, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.